Skip to main content
. Author manuscript; available in PMC: 2019 Sep 16.
Published in final edited form as: J Neuroimmune Pharmacol. 2016 Apr 16;11(2):369–377. doi: 10.1007/s11481-016-9670-0

Fig. 3.

Fig. 3

Absence of B lymphocytes in CCM lesions in a sensitized murine model after B cell depletion. While CCM lesions harbored numerous brown stained CD45R/B220 positive B cells in untreated Pdcd10+/−Trp53−/− mice (left panel), lesions from the same murine model treated with anti-BR3 antibody contained no B cells (right panel). Scale bars are 50 μm